Today, patients with chronic conditions are increasingly administering their own medications, and recent trends point to a prevalence toward injectables, reports Graham Reynolds, VP Marketing & Innovation, West Pharmaceutical Services Inc. “We are now seeing the emergence of alternative systems such as patch injectors and more sophisticated pen systems.

DuPont Medical and Pharmaceutical Protection has announced that Nelson Laboratories will serve as the independent testing laboratory that will generate the data justifying the manufacturing transition of Tyvek 1073B and Tyvek 1059B to DuPont’s latest flash-spinning technology. Nelson Labs will conduct pre- and post-sterilization evaluations of all pouches and header bags, flexible and rigid blisters, and rigid tray-and-lidding combinations provided by medical device manufacturers involved in the transition protocol, which FDA approved in March 2011.